Prevalence of High TG- Low HDL Syndrome and High TG/HDL Ratio in Adults over 20 Years Old in Ahvaz

Document Type : Original Article


1 Internal Medicine Specialist, Endocrinologist.Department of Endocrinology and Metabolism, Faculty of Medicine, University of Medical Sciences, Ahvaz, Ahvaz, Iran.

2 Msc in Biostatistics.Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

3 Professor of Endocrinology.Department of Endocrinology and Metabolism, Faculty of Medicine, University of Medical Sciences, Ahvaz, Ahvaz, Iran.

4 PhD by Research Student,Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.


Background and Objective: The aim of this study was to evaluate the prevalence of high TG-low HDL syndrome and high TG/HDL ratio and its associated factors in Ahvaz.
Subjects and Methods: This descriptive analytical study was performed with cluster sampling method in 6 health centres and 75 households were randomly selected. Blood pressure, weight, height, body mass index (BMI) and waist circumference were measured. Serum fasting level of FBS, total cholesterol, triglyceride, HDL and LDL were measured.
Results: Total 2505 participants [1155 male (46.15%), 1350 female (53.9%)] evaluated in this study. Prevalence of high TG-low HDL was 10.2% (6.5% in male, 13.3% in female) according to American Association of Clinical Endocrinologist (AACE). Prevalence of high TG/HDL ratio was 67.8% with significant difference in male (73.9% in male, 63.7% in female) (P=0.0001). Prevalence of high TG-low HDL and TG/HDL ratio had significant correlation with age (P=0.0001). Both disorders were more prevalent in subjects with diabetes, obesity and high waist circumference than normal weight and normal waist circumference.  
Conclusion: The results shows prevalence of high TG- low HDL and TG/HDL ratio are common disorders in Ahvaz. Educational programs are recommended to improve lifestyles and reduce cardiovascular disease risk factors.


1-Scheidt-Nave C, Du Y, Knopf H, Schienkiewitz A, Ziese T, Nowossadeck E, "et al". Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1).BundesgesundheitsblattGesundheitsforschungGesundheitsschutz 2013May; 56(5-6): 661-7. doi: 10.1007/s00103-013-1670-0.
2-Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, "et al". Seculartrends in serumlipidlevels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis 2014 Jan 23; 13: 20. doi: 10.1186/1476-511X-13-20.
3-Azizi F, Etemadi A, Salehi P, ZahediAsl S. Prevalence of metabolic syndrome in an urban population, Tehran Lipid and Glucose Study(TLGS). Tehran Uni Med J 2003; 61(5): 389-99[Persian].
4-Mascarenhas-Melo F, Palavra F, Marado D, Sereno J, Teixeira-Lemos E, Freitas I, "et al". Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid. Scientific World Journal 2013Nov; (2013): 387849. doi: 10.1155/2013/387849.
5- Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN. Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2011May; 123(20): 2292-333.
6-Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med1993Oct; 153(11): 2209–16.
7-Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001May; 285(19): 2486-97.
8-Barter P, McPherson YR, Song K, Kesäniemi YA, Mahley R, Waeber G, "et al". Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 2007Jun; 92(6): 2041-5.
9-González-Chávez A, Simental-Mendía LE, Elizondo-Argueta S. Elevated triglycerides/HDL-cholesterolratioassociated with insulin resistance. Cir Cir 2011May-Apr; 79(2): 126-31.
10-Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, "et al". AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract 2012Mar-Apr; 18 (Suppl 1): 1-78.
11-Malek M, Ghorbani R, Rashidi pour A, Eskandarian R. Prevalence of Low HDL-C- High TG syndrome in SemnanProviance(2005). Iranian Diabetes Lipid J 2009; 9(1); 75-80.[In Persian].
12-Shahbazian H, Latifi SM, Jalali MT, Shahbazian H, Amani R, Nikhoo A, "et al". Metabolic syndrome and its correlated factors inan urban population in South West of Iran. J Diabetes Metab Disord 2013Feb; 12(1): 11-7.
13-Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, "et al". European Atherosclerosis Society Consensus Panel. Triglyceride-richlipoproteins and high-density lipoprotein cholesterol in patients at highrisk of cardiovasculardisease: evidence and guidance for management. Eur Heart J 2011; 32(11):1345-61.
14-Fazizi F, Esmaillzadeh A, Mirmiran FP. Obesity and cardiovascular diseaserisk factors in Tehranadults: a population-basedstudy. East Mediterr Health J 2004April; 10(6): 887-97.
15-Pintó X, Millán J, Muñoz A, Corbella E, Hernández-Mijares A, Zuñiga M, "et al". A very highprevalence of lowHDL cholesterol in Spanishpatients with acute coronary syndromes. ClinCardiol 2010 Jul; 33(7): 418-23.
16-Laforest L, Souchet T, Moulin P, Ritleng C, Desamericq G, Le Jeunne P, "et al". Prevalence of lowhigh-density lipoprotein cholesterol and hypertriglyceridaemia in patientstreated with hypolipidaemic drugs. Arch Cardiovasc Dis 2009Jan; 102(1): 43-50.
17-Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J. Influence of lowhigh-densitylipoproteincholesterol and elevatedtriglyceride on coronaryheartdiseaseevents and response to simvastatintherapy in 4S. Circulation 2001Dec; 104(25): 3046-51.
18-Connelly PW, Petrasovits A, Stachenko S, MacLean DR, Little JA, "et al". Prevalence of highplasmatriglyceridecombined with lowHDL-Clevels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-Clevels in the Canadianpopulation. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999Apr; 15(4): 428-33.
19-Chan DC, Barrett HP, Watts GF. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs 2004; 4(4): 227-46.
20-Després JP, Moorjani S, Tremblay A, Ferland M, Lupien PJ, Nadeau A. Relation of highplasmatriglyceridelevelsassociated with obesity and regionaladiposetissuedistribution to plasmalipoprotein-lipidcomposition in premenopausal women. Clin Invest Med 1989Dec; 12(6): 374-80.
21-Sarrafzdegan N , Mohammadifard N , Rafiy M. A survey of prevalence of hypertriglyceridemia and low HDL in the population of Isfahan with age over 20 years. Tehran Univ Med J1998; 56 (2): 49-56.
22-Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterolratio is an independentpredictor for coronaryheartdisease in a population of Iranianmen. Nutr Metab Cardiovasc Dis 2009Jul; 19(6): 401-8.
23-Li C, Ford ES, Meng YX, Mokdad AH, Reaven GM. Does the association of the triglyceride to high-densitylipoproteincholesterolratio with fastingseruminsulindiffer by race/ethnicity? Cardiovasc Diabetol 2008; 7: 4-7.
24-Klop B, Elte JW, Cabezas MC. Dyslipidemia in Obesity: Mechanisms and Potential TargetsNutrients. Nutrients 2013Apr; 5(4): 1218-40.
25-Cordero A, Laclaustra M, León M, Grima A, Casasnovas JA, Luengo E, "et al". Prehypertension is associated with insulinresistancestate and not with an initialrenalfunctionimpairment. A MetabolicSyndrome in ActiveSubjects in Spain (MESYAS) Registrysubstudy. Am J Hypertens 2006Feb; 19(2): 189-96.